Alzheimer’s drug won’t forestall memory loss at early stages of the disease, study finds
By Melissa Healy, Los Angeles Times
Follow Us
Melissa Healy is a former health and science reporter with the Los Angeles Times who wrote from the Washington, D.C., area. She covered prescription drugs, obesity, nutrition and exercise, and neuroscience, mental health and human behavior. She was at The Times for more than 30 years, and has covered national security, environment, domestic social policy, Congress and the White House.